|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:BioReference_Laboratories
gptkb:Prolor_Biotech
|
|
gptkbp:CEO
|
gptkb:Phillip_Frost
gptkb:Dr._Phillip_Frost
|
|
gptkbp:clinicalTrials
|
Yes
|
|
gptkbp:collaborations
|
Yes
|
|
gptkbp:employees
|
Approximately 1,000
|
|
gptkbp:focusArea
|
Diagnostics
Therapeutics
|
|
gptkbp:founded
|
2007
|
|
gptkbp:founder
|
gptkb:Phillip_Frost
|
|
gptkbp:headquarters
|
gptkb:Miami,_Florida
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
OPKO Health
|
|
gptkbp:industry
|
Biotechnology
|
|
gptkbp:investmentFocus
|
Yes
|
|
gptkbp:market
|
$1 billion (2021)
|
|
gptkbp:partnerships
|
gptkb:Eli_Lilly
gptkb:Merck
gptkb:GSK
gptkb:AstraZeneca
gptkb:Johnson_&_Johnson
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
gptkb:Teva_Pharmaceuticals
gptkb:Biogen
gptkb:Roche
gptkb:Amgen
gptkb:Gilead_Sciences
gptkb:Vertex_Pharmaceuticals
Novartis
Sanofi
AbbVie
Regeneron
|
|
gptkbp:products
|
gptkb:OPKO_400
gptkb:OPKO_500
gptkb:Rayaldee
gptkb:OPKO_600
gptkb:Vascepa
gptkb:OPKO_200
gptkb:OPKO_300
gptkb:OPKO_1000
gptkb:OPKO_900
gptkb:OPKO_800
Pharmaceuticals
Diagnostic tests
OPKO 700
|
|
gptkbp:researchAndDevelopment
|
Yes
|
|
gptkbp:revenue
|
$100 million (2020)
|
|
gptkbp:stockSymbol
|
OPK
|
|
gptkbp:subsidiary
|
gptkb:OPKO_Diagnostics
gptkb:OPKO_Biologics
|
|
gptkbp:tradedOn
|
gptkb:NASDAQ
|
|
gptkbp:website
|
www.opko.com
|